Pediatric Endocrine Track
Date: October 9, 2020
Accreditation: 5 CME/CE
Schedule: 11:45 AM-6:30 PM EDT
OMA is partnering with the Pediatric Endocrine Society (PES) to offer a one-day track to improve clinicians’ abilities to effectively manage the chronic disease of obesity and associated health conditions in pediatric populations.
The Pediatric Endocrine Track will feature education on complex endocrine disorders and complications associated with obesity, including polycystic ovarian syndrome (PCOS), dyslipidemia, and hypothalamic obesity. These sessions will review assessment and evaluation strategies as well as evidence-based treatment modalities for diagnosing and individualizing treatment for these conditions in pediatric patients with obesity.
The Pediatric Endocrine Track will be held during the Fall Obesity Summit – Virtual.
The Pediatric Track is part of the Fall Obesity Summit – Virtual on Friday, Oct. 9.
All times displayed in Eastern Daylight Time (EDT)
11:45-12:30 PM - Diagnosis and Treatment of Polycystic Ovarian Syndrome in Adolescent Girls
Anshu Gupta, MD
Polycystic ovarian syndrome is a common obesity-associated endocrinopathy in adolescent girls. In this session, we will discuss challenges associated with making the diagnosis of PCOS in adolescent girls based on current criteria and review common pitfalls in testing. Additionally, participants will develop an individualized treatment plan that specifically addresses the concerns of an adolescent girl diagnosed with PCOS.
- Discuss challenges associated with current criteria for the diagnosis of PCOS in adolescent girls.
- Recognize common pitfalls in the diagnostic laboratory testing for PCOS in adolescent girls.
- Develop an individualized treatment plan to address the concerns of an adolescent girl with PCOS.
12:30-1:30 PM - Pediatric Dyslipidemia
Ambika Ashraf, MD, FAAP
With the epidemic of childhood obesity, pediatric practitioners are required to provide appropriate management of dyslipidemia that includes testing, assessing risk, and providing treatment. Multiple metabolic comorbities such as insulin resistance, metabolic syndrome, diabetes, and hypertension complicate dyslipidemia prevalent in children and adolescents with obesity. This talk will discuss the management approach to the spectrum of dyslipidemia seen in children with obesity.
- Discuss an overview of dyslipidemia in children with obesity
- Assess elevated low-density lipoprotein cholesterol levels
- Review the management strategies for elevated triglycerides
- Evaluate mixed dyslipidemia in children and adolescents
1:30-2:45 PM - Exhibit Hall Break
Optional CME Lunch (1:35 – 2:35pm EDT): Early-onset, Severe Obesity and Hyperphagia: Can Rare Genetic Variants be the Cause?
Heidi C. Shea, MD, FAAP, FACE
Sonali Malhotra, MD
Gitanjali Srivastava, MD, FAAP, FACP
2:45-3:45 PM - Pharmacotherapy in Pediatric Obesity
Vibha Singhal, MD
The prevalence of pediatric obesity, especially severe obesity continues to rise particularly among minority groups. The treatment of pediatric obesity is crucial as it have severe metabolic and psychosocial consequences. The current common approach of treatment of pediatric obesity with only lifestyle and behavioral intervention has only modest benefits. Knowledge and utilization of the benefits of anti-obesity medications in children will help improve outcomes of pediatric obesity.
- Understand the rationale for the use of pharmacotherapy in pediatric obesity
- Discuss the available pediatric data of the commonly used weight loss medications in adults
- Discuss the challenges in the use of these medications in children
4:30-5:00 PM - Exhibit Hall Break
Virtually visit the exhibitors and explore the latest technologies, products, and services available to enhance and improve your practice. Meet with exhibitors, try samples, and discover new tools to use when treating patients with obesity.
5:00-5:45 PM - Motivational Interviewing and Pediatric Obesity: Clinical Conversations and Behavior Change
Melanie Bean, PhD
This session will provide an overview of motivational interviewing and its application to pediatric obesity. Dr. Bean will emphasize both the spirit of motivational interviewing as well as practical skills-based content that providers can apply to their interactions with pediatric patients with obesity.
- Identify the spirit of motivational interviewing, and how this empirically supported treatment differs from the traditional medical paradigm.
- Verbalize the core skills used in motivational interviewing.
- Identify areas in clinical practice where motivational can be effective to enhance patient outcomes and improve provider satisfaction.
5:45-6:30 PM - Pediatric Endocrine Panel
Melanie Bean, PhD
Anshu Gupta, MD
Shana E. McCormack, MD, MTR
To attend the Pediatric Track, you can register for either the Fall Obesity Summit – Virtual (Oct. 9-11) or the Friday One-Day Pass (Oct. 9).
This education activity may receive support through an educational grant from a commercial interest.